The first reports of monkeypox cases in Europe began to surface in mid-May. A week later, there were 92 confirmed cases outside the Central and West African countries where the disease usually circulates; now there are 1,200.
In this, the season of Bill Gates’s atonement, the billionaire is willing to acknowledge that things don’t always turn out as they should have, and that—at least in some cases—that’s on him.
More than two years into this pandemic, we finally have an antiviral treatment that works pretty darn well. Paxlovid cuts a vulnerable adult’s chances of hospitalization or death from COVID by nearly 90 percent if taken in the first few days of an infection. For adults without risk-heightening factors, it reduces that likelihood by 70 percent. Also, it might make your mouth taste like absolute garbage the whole time you’re taking the pills.In Pfizer’s clinical trials, about 5.
Updated at 6:50 p.m. ET on April 20, 2022If you commuted to work today on a bus, train, or metro system, you probably saw more mouths and noses than usual. On Monday, a Trump-appointed federal judge struck down a CDC rule that mandated masks on all U.S. transportation networks, including in airports and on planes.
The FDA and CDC have cleared the way for Americans older than 50 to get a second booster shot—but they don’t quite suggest that everyone in that age group should do so. Like masking and many other pandemic-control measures, a fourth dose (or third, for the J&Jers in the back) is now a matter of personal judgment, even as another wave of COVID cases seems poised to break. That leaves millions of Americans and their doctors to perform their own risk-benefit analysis.
About three weeks ago, COVID case rates in the United Kingdom made an abrupt about-face, spurred on by a more transmissible Omicron subvariant called BA.2. (So far, there is no reason to believe the new subvariant causes more severe disease.) Case rates are rising, too, in Switzerland and Greece and Monaco and Italy and France. Given that BA.
Updated at 7:34 p.m. ET on March 15, 2022 Imagine if older Americans had been forced to weather the past three months without the option of a booster shot. Having an additional vaccine dose during the Omicron surge cut seniors’ risks of hospitalization and death by more than 70 percent.
Russia has launched a full-scale invasion of Ukraine, sending troops over the border and shelling cities across the country. Already, dozens of Ukrainian soldiers have been killed in the assault, and millions more people in the region are now in mortal danger. Countries around the world are likely to feel some effects as well, via physical disruptions of agricultural and energy supplies, and digital disruptions caused by Russian cyberattacks.
When the mayor of Washington, D.C., announced changes to the city’s mask mandate last week, spit hit the fan. As of March 1, District residents will need to cover up in order to attend school, go to a library, or ride in a taxi. But gyms, sports arenas, concert venues, and houses of worship—you know, all the places where people like to breathe hard or sing and shout in close proximity—will be facial free-for-alls.
“It started as a joke, actually,” Elena Korngold told me. But late last month, the 40-something radiologist from Portland, Oregon, and her family decided that their unsanctioned scheme couldn’t hurt. Elena began the proceedings by unwrapping the sterile swab from a BinaxNOW rapid test for SARS-CoV-2, part of the family’s dwindling supply. She swirled the swab around the insides of each of her nostrils.
Last week in the United States, more than 1 million COVID-19 cases were reported in a single day, schools resorted to virtual instruction, and COVID outbreaks among staff left hospitals struggling to attend to their ever-growing number of COVID patients. Also, the CDC endorsed Pfizer booster shots for teenagers, saying not only that every American 12 and up can get one, but that they should.
You know that moment, just after you get a batch of cookies in the oven, when you take off your apron, place the mixing bowl neatly in the sink, fill it with water, and wash your hands to celebrate a job well done? Well, congratulations if you do. I’ve certainly never experienced it.As soon as I’ve formed the last reasonably sized cookie, my grubby little paws go straight for the dough that’s sticking to the side of the bowl.
Even before the arrival of Omicron, the winter months were going to be tough for parts of the United States. While COVID transmission rates in the South caught fire over the summer, the Northeast and Great Plains states were largely spared thanks to cyclical factors and high vaccination rates. But weather and the patterns of human life were bound to shift the disease burden northward for the holidays—and that was just with Delta.
World, meet Omicron; Omicron, meet a lot of people who are very, very anxious to know more about you.The arrival of the newest coronavirus variant, first identified in Botswana and South Africa and now present in the United States, might be bad news, or it might be terrible news—or maybe it’s just a temporary distraction from Delta.
The first part of what may be the first epidemiologic text ever written begins like so: “Whoever wishes to investigate medicine properly, should proceed thus: in the first place to consider the seasons of the year.”The book is On Airs, Waters, and Places, written by Hippocrates around 400 B.C. Two and a half millennia later, the Northern Hemisphere is staring down its coming season of the year with growing apprehension.
COVID-19 vaccination for 5-to-11-year-olds is finally a go. But even as the emergency-use-authorization process unfolded, so too did arguments over whether kids should (or would soon) be forced into getting shots. School mandates for new vaccines tend to lag behind CDC recommendations by about half a decade, but COVID-19 shots appear to be in the express lane.
In this week’s installment of the booster chronicles, the plot is picking up. An advisory committee to the FDA began a two-day meeting today to formulate recommendations for whether the agency should authorize additional doses of the Johnson & Johnson and Moderna COVID-19 vaccines. (The FDA still has to authorize, and the CDC still has to recommend, any new use of boosters before they’ll be readily available.
Editor’s Note: This article is part of our coverage of The Atlantic Festival. Learn more and watch festival sessions here. A week after FDA and CDC advisory committees clashed on the nuances of when and whether to recommend COVID-19 booster shots, Anthony Fauci told my colleague Ed Yong that he still believes third doses of the mRNA vaccines are crucial, suggesting once again that they will eventually be part of a standard regimen.
The definition of full vaccination against COVID-19 has, since the winter, been somewhat difficult to nail down. It takes one dose of Johnson & Johnson, but two doses of an mRNA vaccine. The CDC counts you as fully vaccinated as soon as you get your last shot, but tells you that you won’t be fully vaccinated until two weeks after that. People have a hard time knowing exactly when it might be safe for them to venture into restaurants, wedding venues, or mask-free offices.
After a long and tense meeting today, an FDA committee unanimously recommended that the agency authorize third shots of the Pfizer COVID-19 vaccine for Americans who are over 65 or at high risk of severe COVID. The vote came after the panel voted overwhelmingly against the original question up for its consideration: authorizing boosters for everyone over 16.
Updated at 8:15 p.m. ET on August 17, 2021At this point, COVID-19 booster shots seem all but guaranteed for Americans. Last night, The New York Times and The Wall Street Journal reported that the White House plans to recommend a third dose of COVID-19 vaccine to most Americans who have already gotten two shots from Pfizer or Moderna. The news comes just five days after the FDA authorized third doses for people who have received organ transplants or have certain immune conditions.
Updated at 5:10 p.m. ET on August 11, 2021.The timing of the latest COVID-19 surge isn’t great for children. Millions have already started the school year, the rest will do so in the coming weeks, and COVID-19 vaccines aren’t yet available for the 50 million Americans who haven’t reached their 12th birthday.Vaccine availability will not bring this pediatric outbreak to a halt.
If your wanderlust is coming on extra strong this summer, you may be wondering what to do with it. Being vaccinated may feel like a superpower, but what exactly is safe—or not?The CDC suggests, for example, that this may be the summer for road-tripping by RV.
Lidia Morawska has been working in her office for months. You might think that’s because she’s an aerosols expert, and her work is crucial for helping bring the pandemic to heel. But really, it’s because she’s an aerosols expert at Queensland University of Technology, in Australia. The country has recorded only three cases of community transmission of the coronavirus in the past week.
Editor’s Note: The Atlantic is making vital coverage of the coronavirus available to all readers. Find the collection here. Americans’ social lifelines are beginning to fray. As the temperature drops and the gray twilight arrives earlier each day, comfortably mingling outside during the pandemic is getting more difficult across much of the country. For many people, it’s already impossible.
Photographs by Dina LitovskyThe Lesbian & Gay Big Apple Corps, one of the first queer marching bands in the United States, was founded in 1979 in New York City, a decade after the Stonewall uprising. This year, the Big Apple Corps reached what Marita Begley, the group’s director, called “the mountaintop”: Tomorrow, it will become the first openly LGBTQ group to perform in the Macy’s Thanksgiving Day Parade.